Know Cancer

or
forgot password
  • cancer clinical trials in boston, MA

  • Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Mucosal Melanoma, Acral Melanoma, Melanoma
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Boston University Cancer Research Center
    Boston, Massachusetts 02118
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Melanoma
    A Pilot Study of Acupuncture Treatment for Dysphagia
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Carcinomas, Squamous Cell, Dysphagia
    Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Brigham & Women's Hospital
    Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
    Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Brigham & Women's Hospital
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Brigham and Women's Hospital

    Trial Locations
    Brigham and Women's Hospital
    Tufts Medical Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine Tumor
    A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
    Site Reference ID/Investigator# 14610

    Trial Locations
    Site Reference ID/Investigator# 14610
    Site Reference ID/Investigator# 21462
    Site Reference ID/Investigator# 21461
    Melanoma, Metastatic Melanoma, Skin Cancer
    CyberKnife for Unresectable Renal Tumors
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Renal Cancer
    Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Urothelial Cancer, Muscle-invasive Urothelial Carcinoma
    Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Hepatocellular Cancer
    RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Acute Myeloid Leukemia, Myelodysplastic Syndrome
    Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Dana-Farber/Brigham and Women's Cancer Center
    Boston University Cancer Research Center
    Lymphoma
    Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Renal Cell Carcinoma, Renal Cancer
    Polyethylene Glycol 3350 in Preventing Cancer in Patients at Risk of Colorectal Cancer
    Boston Medical Center
    Boston, Massachusetts 02118
    Adenomatous Polyp, Colorectal Cancer, Precancerous Condition
    Characterization of Prostate Cancer With 3T MR
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Prostate Cancer
    Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Small Bowel Cancer, Pancreatic Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Multiple Myeloma
    Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Harvard Cancer Center
    Hodgkin Lymphoma
    Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer
    Boston University Cancer Research Center
    Boston, Massachusetts 02118
    Head and Neck Cancer
    Lung Cancer Symptom Assessment and Management Intervention
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Boston Medical Center
    Lung Cancer